Freja Ekman
Freja Ekman is interested in engineering novel gene therapies to target rare genetic diseases and using computational genomics to better characterize them. She is currently pursuing her MD-PhD at Stanford University, where she is working with Professor Matthew Porteus to develop CRISPR/Cas9-based gene therapies to target hematopoietic diseases and create new cancer immunotherapies. Prior to … Read more
